Frazier Life Sciences Acquisition Corp. II - 10-Q Filing

Frazier Life Sciences Acquisition Corp. II reports net loss of $112,569 for the period from inception through September 30, 2026.

SEC EDGAR ·

Tickers: $FLSC

Read the full article at SEC EDGAR

More Regulatory news